Daiwa Securities Group Inc. Abcam PLC Transaction History

Daiwa Securities Group Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$21.54 - $24.41 $166,159 - $188,298	-7,714 Reduced 90.22%	836 $19,000
Q2 2023 Jul 31, 2023	SELL	$12.62 - $24.47 $3,571 - $6,925	-283 Reduced 3.2%	8,550 $209,000
Q1 2023 May 02, 2023	BUY	$12.98 - $17.1 $5,750 - $7,575	443 Added 5.28%	8,833 $119,000
Q4 2022 Feb 06, 2023	BUY	$13.92 - $17.0 $1,252 - $1,530	90 Added 1.08%	8,390 $131,000
Q3 2022 Nov 02, 2022	SELL	$13.36 - $16.75 $2,992 - $3,752	-224 Reduced 2.63%	8,300 $124,000
Q2 2022 Aug 09, 2022	SELL	$12.69 - $19.25 $11,205 - $16,997	-883 Reduced 9.39%	8,524 $123,000
Q1 2022 Apr 29, 2022	SELL	$15.5 - $23.89 $1,162 - $1,791	-75 Reduced 0.79%	9,407 $172,000
Q4 2021 Feb 03, 2022	SELL	$20.04 - $23.84 $23,446 - $27,892	-1,170 Reduced 10.98%	9,482 $224,000
Q3 2021 Nov 05, 2021	BUY	$17.38 - $21.54 $1,129 - $1,400	65 Added 0.61%	10,652 $216,000
Q2 2021 Aug 06, 2021	SELL	$18.47 - $22.11 $29,238 - $35,000	-1,583 Reduced 13.01%	10,587 $202,000
Q1 2021 May 03, 2021	SELL	$19.22 - $24.3 $14,318 - $18,103	-745 Reduced 5.77%	12,170 $234,000
Q4 2020 Feb 04, 2021	BUY	$18.2 - $22.45 $235,053 - $289,941	12,915 New	12,915 $278,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.